Overall and disease-free survival in patients treated with CRS + HIPEC with cisplatin and paclitaxel for gastric cancer with peritoneal carcinomatosis

BACKGROUND: Our experience regarding cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) was reviewed in terms of overall survival (OS) and disease-free survival (DFS) in patients with synchronous peritoneal carcinomatosis (SPC) and metachronous peritoneal carcinomatosi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Gastrointest Oncol
Päätekijät: Fugazzola, Paola, Coccolini, Federico, Montori, Giulia, Ceresoli, Marco, Baggi, Paolo, Costanzo, Antonio, Tomasoni, Matteo, Gregis, Francesco, Nozza, Silvia, Ansaloni, Luca
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: AME Publishing Company 2017
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5506286/
https://ncbi.nlm.nih.gov/pubmed/28736644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2017.03.11
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia